Literature DB >> 23142975

Splice variants of the Alzheimer's disease beta-secretase, BACE1.

R M Damian Holsinger1, Nelleke Goense, John Bohorquez, Padraig Strappe.   

Abstract

Cleavage of the amyloid precursor protein by enzymes commonly referred to as β- and γ-secretase constitute an important process in the pathogenesis of Alzheimer's disease (AD). The regulation of this process is therefore an important subject of investigation. Numerous sources of endogenous regulation have been identified, and one of these is the relative abundance and regulation of splice variants of the β-secretase, BACE1 (β-site amyloid precursor protein cleaving enzyme 1). In this review, we will briefly discuss the main characteristics of BACE1, review the different variants of this enzyme that have been identified to date, and highlight their possible implication in AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142975     DOI: 10.1007/s10048-012-0348-3

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  49 in total

1.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

2.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 3.  Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

Authors:  T E Golde; C B Eckman; S G Younkin
Journal:  Biochim Biophys Acta       Date:  2000-07-26

4.  CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.

Authors:  R M D Holsinger; J S Lee; A Boyd; C L Masters; S J Collins
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

5.  Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties.

Authors:  M Haniu; P Denis; Y Young; E A Mendiaz; J Fuller; J O Hui; B D Bennett; S Kahn; S Ross; T Burgess; V Katta; G Rogers; R Vassar; M Citron
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.

Authors:  Diana Dominguez; Jos Tournoy; Dieter Hartmann; Tobias Huth; Kim Cryns; Siska Deforce; Lutgarde Serneels; Ira Espuny Camacho; Els Marjaux; Katleen Craessaerts; Anton J M Roebroek; Michael Schwake; Rudi D'Hooge; Patricia Bach; Ulrich Kalinke; Dieder Moechars; Christian Alzheimer; Karina Reiss; Paul Saftig; Bart De Strooper
Journal:  J Biol Chem       Date:  2005-06-29       Impact factor: 5.157

7.  The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate.

Authors:  Christine A F von Arnim; Ayae Kinoshita; Ithan D Peltan; Michelle M Tangredi; Lauren Herl; Bonny M Lee; Robert Spoelgen; Tammy T Hshieh; Sripriya Ranganathan; Frances D Battey; Chun-Xiang Liu; Brian J Bacskai; Sanja Sever; Michael C Irizarry; Dudley K Strickland; Bradley T Hyman
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

8.  BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes.

Authors:  Steve M Harrison; Alex J Harper; Julie Hawkins; Graham Duddy; Evelyn Grau; Pippa L Pugh; Panida H Winter; Claire S Shilliam; Zoë A Hughes; Lee A Dawson; M Isabel Gonzalez; Neil Upton; Menelas N Pangalos; Colin Dingwall
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

9.  A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.

Authors:  Hiroshi Tanahashi; Takeshi Tabira
Journal:  Neurosci Lett       Date:  2007-09-26       Impact factor: 3.046

10.  Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production.

Authors:  Karen R Mowrer; Michael S Wolfe
Journal:  J Biol Chem       Date:  2008-05-08       Impact factor: 5.157

View more
  3 in total

Review 1.  The biological pathways of Alzheimer disease: a review.

Authors:  Marco Calabrò; Carmela Rinaldi; Giuseppe Santoro; Concetta Crisafulli
Journal:  AIMS Neurosci       Date:  2020-12-16

2.  Is It the Twilight of BACE1 Inhibitors?

Authors:  Martina Hrabinova; Jaroslav Pejchal; Tomas Kucera; Daniel Jun; Monika Schmidt; Ondrej Soukup
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

3.  BACE1 gene silencing alleviates isoflurane anesthesia‑induced postoperative cognitive dysfunction in immature rats by activating the PI3K/Akt signaling pathway.

Authors:  Ying-Bin Wang; Jian-Qin Xie; Wei Liu; Rong-Zhi Zhang; Sheng-Hui Huang; Yan-Hong Xing
Journal:  Mol Med Rep       Date:  2018-09-04       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.